Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4861
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTas, Beray Gelmez-
dc.contributor.authorDemir, Ilknur-
dc.contributor.authorBasanmay, Muhammed-
dc.contributor.authorOzturk, Guzin Zeren-
dc.contributor.authorAkyol, Bestegul Coruh-
dc.contributor.authorTektas, Merve Hicret-
dc.contributor.authorOzdemir, Haci Mustafa-
dc.date.accessioned2024-03-21T11:45:22Z-
dc.date.available2024-03-21T11:45:22Z-
dc.date.issued2023-
dc.identifier.citationTas, BG., Demir, I., Basanmay, M., Öztürk, GZ., Akyol, BÇ., Tektas, MH., Özdemir, H. (2023). Frequency And Factors Associated With Adverse Reactions After Administration of Inactivated COVID-19 Vaccine Among Health Workers. Rev. Soc. Bras. Med. Trop., 56. https://doi.org/10.1590/0037-8682-0152-2023en_US
dc.identifier.issn0037-8682-
dc.identifier.urihttp://dx.doi.org/10.1590/0037-8682-0152-2023-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:001084564700001-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4861-
dc.descriptionWoS Categories: Parasitology; Tropical Medicineen_US
dc.descriptionWeb of Science Index: Science Citation Index Expanded (SCI-EXPANDED)en_US
dc.descriptionResearch Areas: Parasitology; Tropical Medicineen_US
dc.description.abstractBackground: The 2019 coronavirus (COVID-19) has precipitated a significant public health crisis. Our study aimed to evaluate the prevalence and risk factors associated with adverse reactions to the inactivated CoronaVac vaccine.Methods: The study involved voluntary health workers who received CoronaVac vaccine. We documented the sociodemographic information of 2,019 participants who volunteered for our study. Of these, 1,964 and 1,702 participants were interviewed by phone 1 month after the first and second dose, respectively, during which they were queried about any adverse reactions.Results: Within the first week after the first dose, adverse reactions were observed in 856 (43.3%) participants, with 133 (6.7%) experiencing them during the second week, and 96 (4.9%) people at the end of the first month. For the second dose, 276 individuals (16.2%) reported adverse reactions. The prevalence of both local and systemic adverse events ranged from 9.5-11.2% overall. Fatigue was the most common adverse reaction overall, while pain at the injection site was the most frequent local adverse reaction.Conclusions: The evaluation of both systemic and local side effects revealed no significant adverse reactions to the inactivated CoronaVac vaccine (Sinovac Life Sciences, Beijing, China). Our study found that the incidence of systemic and local adverse responses to the CoronaVac vaccination was lower than the rates reported in studies involving the recombinant adenovirus type-5, BNT162b1, and ChAdOx1nCoV-19 COVID-19 vaccines, all of which underwent the World Health Organization LULUC/PQ evaluation process.en_US
dc.language.isoengen_US
dc.publisherSOC BRASILEIRA MEDICINA TROPICAL-BRASILIAen_US
dc.relation.isversionof10.1590/0037-8682-0152-2023en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19 vaccines. Adverse reactions. CoronaVac vaccine.en_US
dc.titleFrequency And Factors Associated With Adverse Reactions After Administration of Inactivated COVID-19 Vaccine Among Health Workersen_US
dc.typearticleen_US
dc.relation.journalREVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICALen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0002-7126-0024en_US
dc.contributor.authorID0000-0003-0055-7186en_US
dc.identifier.volume56en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.